EP0438052B1 - Verfahren zur Herstellung von Vitamin A Aldehyd - Google Patents
Verfahren zur Herstellung von Vitamin A Aldehyd Download PDFInfo
- Publication number
- EP0438052B1 EP0438052B1 EP91100046A EP91100046A EP0438052B1 EP 0438052 B1 EP0438052 B1 EP 0438052B1 EP 91100046 A EP91100046 A EP 91100046A EP 91100046 A EP91100046 A EP 91100046A EP 0438052 B1 EP0438052 B1 EP 0438052B1
- Authority
- EP
- European Patent Office
- Prior art keywords
- vitamin
- aldehyde
- reaction
- aluminum
- amount
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C403/00—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone
- C07C403/06—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by singly-bound oxygen atoms
- C07C403/08—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by singly-bound oxygen atoms by hydroxy groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C403/00—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone
- C07C403/14—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by doubly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated
Definitions
- This invention relates to a process for producing vitamin A aldehyde (retinal).
- Vitamin A aldehyde is not only a valuable biologically active substance as itself but also a useful starting material for producing carotene.
- vitamin A aldehyde As a simple and easy productin process of vitamin A aldehyde, there is known a process oxidizing vitamin A obtained by the hydrolysis of commercially available vitamin A acetate.
- vitamin A or vitamin A aldehyde is thermally unstable because they have not only a number of double bonds sensitive to oxidation but also highly reactive allyl alcohol or ⁇ , ⁇ -unsaturated aldehyde structures, and further they must be handled under a condition cut off light and oxygen.
- vitamin A has all double bonds in trans form, so that it is required to be transformed into vitamin A aldehyde having all double bonds in trans form unchanged without isomerization.
- the method (1) requires a large excess amount of solid metal oxide relative to vitamin A. And also the yield by the mothod (1) depends on the activity of the metal oxide.
- the method (2) requires an expensive platinum catalyst, and also has a lower yield.
- the method (3) requires expensive 4-oxo-2,2,6,6-tetramethylpiperidine-1-oxyl as a catalyst and also a solvent having a higher boiling point such as N,N-dimethylformamide.
- the medhod (4) requires a severe reaction condition resulting in a lower yield.
- An object of the invention is to provide a process for producing vitamin A aldehyde from vitamin A economically and in high yield without isomerization.
- the aforementioned object can be accomplished by a process comprising the reaction of vitamin A with the aldehydes of the general formula (1) wherein R1, R2 and R3 are the same or different and respectively represents a lower alkyl group or a lower alkenyl group in the presence of catalytic amount of an aluminum alkoxide or an aluminum phenoxide.
- R1, R2 and R3 in the general formula (1) are described in detail.
- R1, R2 and R3 of the general formula (1) respectively represents a lower alkyl or a lower alkenyl group.
- Lower alkyl groups are C1 ⁇ 10 alkyl groups, preferably C1 ⁇ 4 allyl groups, such as a methyl group, an ethyl group, a n-propyl group, an i-propyl group, a n-butyl group, a sec-butyl group, a t-butyl group and the like.
- Lower alkenyl group are C1 ⁇ 10 alkenyl groups, preferably C2 ⁇ 5 alkenyl groups, such as a vinyl group, an allyl group, a 2-methyl-2-propenyl group, a 3-methyl-3-butenyl group, a 3-methyl-2-butenyl group, an allenyl group and the like. Further R1, R2 and R3 respectively are different or two or three of them are the same.
- aldehyde of the general formula (1) examples include trimethylacetaldehyde, 2,2-dimethylbutanal, 2-ethyl-2-methylbutanal, 2, 2-dimethyl-4-pentenal, 2,2-dimethylpentanal, 2,2-dimethylpenta-3,4-dienal and the like.
- trimethylacetaldehyde (boiling point 74 °C at 730 mmHg) and 2,2-dimethy-4-pentenal (boiling point 124°C at 760 mmHg) are preferable examples of the invention because the both substances themselves and the corresponding alcohols formed at the preparation of vitamin A aldehyde as side products have lower boiling points, so that these materials can be easily removed from the reaction mixtures at lower temperatures after the completion of the reaction.
- the amount of the aldehyde of the general formula (1) is one or more equivalents relative to the amount of vitamin A to be oxidized, but preferably in the range of from 1.1 to 3 equivalents for efficiently and economically carrying out of the reaction.
- Examples of aluminum alkoxides used as the catalyst of the reaction are derived from C 1-10' preferably C1 ⁇ 4, alcohols and include aluminum isopropoxide, aluminum tert-butoxide and aluminum sec-butoxide.
- Examples of aluminum phenoxides are derived from optionally substituted phenols and include aluminum phenoxide (Al(OPh)3).
- Aluminum isopropoxide is preferably used from the standpoint of versatility and economy.
- the amount of aluminum catalyst to be used is in the range of from 0.1 to 30 mole percent relative to vitamin A to be oxidized, however, normally an amount of the catalyst in the range of from 2 to 10 mole percent is used.
- the reaction is carried out at a temperature ranging from 10°C to 80°C depending on the reaction period, however, preferably ranging from 20°C to 50°C considering the stability of formed vitamin A aldehyde.
- a solvent selected from the group consisting of hydrocarbon type solvents such as toluene, hexane, etc., halogenated hydrocarbon type solvents such as methylene chloride, chloroform, etc., ether type solvents such as tetrahydrofuran, diethyl ether, etc., and ester type solvents such as ethyl acetate, etc. can be used.
- hydrocarbon type solvents such as toluene, hexane, etc.
- halogenated hydrocarbon type solvents such as methylene chloride, chloroform, etc.
- ether type solvents such as tetrahydrofuran, diethyl ether, etc.
- ester type solvents such as ethyl acetate, etc.
- the reaction period of the reaction is normally in the range of from 10 min. to 2 hours depending on the amount of catalyst used and the reaction temperature.
- Stopping of the reaction is accomplished by the addition of water, aqueous hydrochloric acid solution, aqueous sulfuric acid solution and the like. After the addition of small amount of water for stopping the reaction, the aldehyde of the general formula (1) used for the reaction and the alcohol formed as a reaction byproduct are distilled off from the reaction mixture under a reduced pressure, followed by the purification and separation directly from the residue by means of column chromatography or recrystallization to obtain the objective vitamin A aldehyde easily.
- the reaction mixture is extracted by an organic solvent such as toluene, hexane, diethyl ether, methylene chloride, ethyl acetate or the like, and subjected to separation.
- organic solvent such as toluene, hexane, diethyl ether, methylene chloride, ethyl acetate or the like, and subjected to separation.
- the organic solvent is removed and thereafter subjected to column chromatography or recrystallization for the separation and purification to obtain the objective vitamin A aldehyde.
- the obtained crude vitamin A aldehyde was recrystallized from hexane to obtain 1.45 g of purified vitamin A aldehyde (melting point 60-61°C).
- the obtained crude vitamin A aldehyde was recrystallized from hexane to obtain 1.25 g of purified vitamin A aldehyde (melting point 60-61°C).
- Vitamin A aldehyde was prepared by the method described in Hawkins, et.al., J. Chem. Soc. 411 (1944).
- reaction mixture was cooled and added 30 ml of water, the reaction mixture was vigorously agitated, thereafter solids in the reaction mixture were removed by filteration with Celite.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Claims (6)
- Verfahren zur Herstellung von Vitamin A-Aldehyd, umfassend die Umsetzung von Vitamin A mit einem Aldehyd der allgemeinen Formel (1)
- Verfahren nach Anspruch 1, wobei der Aldehyd Trimethylacetaldehyd oder 2,2-Dimethyl-4-pentenal ist.
- Verfahren nach Anspruch 1 oder 2, wobei der Aldehyd in einer Menge von 1 oder mehreren Äquivalent(en), bezogen auf Vitamin A, verwendet wird.
- Verfahren nach Anspruch 3, wobei der Aldehyd in einer Menge im Bereich von 1,1 bis 3 Äquivalenten, bezogen auf Vitamin A, verwendet wird.
- Verfahren nach einem der Ansprüche 1 bis 4, wobei das Aluminiumalkoxid oder -phenoxid in einer Menge im Bereich von 0,1 bis 30 Mol-%, bezogen auf Vitamin A, verwendet wird.
- Verfahren nach einem der Ansprüche 1 bis 5, wobei die Umsetzung bei einer Temperatur im Bereich von 10 bis 80°C durchgeführt wird.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AT9191100046T ATE104959T1 (de) | 1990-01-08 | 1991-01-02 | Verfahren zur herstellung von vitamin a aldehyd. |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1948/90 | 1990-01-08 | ||
JP2001948A JPH07103095B2 (ja) | 1990-01-08 | 1990-01-08 | ビタミンaアルデヒドの製造方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
EP0438052A1 EP0438052A1 (de) | 1991-07-24 |
EP0438052B1 true EP0438052B1 (de) | 1994-04-27 |
Family
ID=11515830
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP91100046A Expired - Lifetime EP0438052B1 (de) | 1990-01-08 | 1991-01-02 | Verfahren zur Herstellung von Vitamin A Aldehyd |
Country Status (6)
Country | Link |
---|---|
US (1) | US5087762A (de) |
EP (1) | EP0438052B1 (de) |
JP (1) | JPH07103095B2 (de) |
AT (1) | ATE104959T1 (de) |
DE (1) | DE69101790T2 (de) |
ES (1) | ES2055926T3 (de) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19926090A1 (de) | 1998-06-12 | 1999-12-16 | Sumitomo Chemical Co | Verfahren und Zwischenprodukt zur Herstellung von Retinal |
DE10026750A1 (de) | 1999-06-03 | 2001-01-18 | Sumitomo Chemical Co | Verfahren zur Herstellung von Retinin und Zwischenprodukte zur Herstellung desselben |
JP2001114755A (ja) | 1999-10-12 | 2001-04-24 | Sumitomo Chem Co Ltd | ビタミンaアルデヒドの製造方法および中間体 |
WO2024042131A1 (en) | 2022-08-24 | 2024-02-29 | Basf Se | Method for preparing 4-hydroxy-2-methylene-butanal, 4-hydroxy-2-methyl-but-2-enal and esters thereof |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2819311A (en) * | 1955-11-04 | 1958-01-07 | Nopco Chem Co | Production of vitamin a aldehyde |
GB861460A (en) * | 1957-01-28 | 1961-02-22 | Takeda Pharmaceutical | Production of vitamin a aldehyde |
US3060229A (en) * | 1959-12-21 | 1962-10-23 | Bayer Ag | Process for the production of vitamin-acompounds |
DE2556161A1 (de) * | 1975-05-30 | 1976-12-16 | Scm Corp | Verfahren zur oxidation primaerer allyl- und benzylalkohole |
US4148829A (en) * | 1975-08-11 | 1979-04-10 | Hoffmann-La Roche Inc. | Process for producing vitamin A |
-
1990
- 1990-01-08 JP JP2001948A patent/JPH07103095B2/ja not_active Expired - Fee Related
- 1990-11-28 US US07/618,922 patent/US5087762A/en not_active Expired - Lifetime
-
1991
- 1991-01-02 AT AT9191100046T patent/ATE104959T1/de not_active IP Right Cessation
- 1991-01-02 EP EP91100046A patent/EP0438052B1/de not_active Expired - Lifetime
- 1991-01-02 ES ES91100046T patent/ES2055926T3/es not_active Expired - Lifetime
- 1991-01-02 DE DE69101790T patent/DE69101790T2/de not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
ATE104959T1 (de) | 1994-05-15 |
EP0438052A1 (de) | 1991-07-24 |
JPH07103095B2 (ja) | 1995-11-08 |
DE69101790T2 (de) | 1994-08-11 |
US5087762A (en) | 1992-02-11 |
DE69101790D1 (de) | 1994-06-01 |
JPH03206076A (ja) | 1991-09-09 |
ES2055926T3 (es) | 1994-09-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4107439A (en) | Process for preparing arylalkanoic acid derivatives | |
Gilbert et al. | Enantioselective synthesis of (-)-trichodiene | |
EP0438052B1 (de) | Verfahren zur Herstellung von Vitamin A Aldehyd | |
JPS5826331B2 (ja) | 立体規制されたファルネシル酢酸エステルの製造方法 | |
IE54216B1 (en) | Stereospecific synthesis of 5-phenyl-2s-pentanol | |
JP4508642B2 (ja) | トリメチルヒドロキノンジアシレートの製造 | |
US3992452A (en) | Method for the production of alkoxycyclohexanones | |
US5053550A (en) | Preparation of formylcyclopropane | |
Goering et al. | Preparation and determination of absolute rotations and configurations of 6, 7-dimethoxy-1, 2-dimethyl-exo-2-benzonorbornenyl derivatives | |
USRE29200E (en) | Production of alkoxy phenolic compounds | |
USRE29201E (en) | Production of alkoxy phenolic compounds | |
JP3529876B2 (ja) | 3−メチル−3−メトキシブタン酸。 | |
JPH05155815A (ja) | グリセロール誘導体の製造方法 | |
EP0204286A2 (de) | Herstellungsverfahren von Estern der Trans-alpha-benzoylacrylsäure | |
US5627288A (en) | Method for producing rosefuran precursor and intermediates therefor | |
JPS6042775B2 (ja) | 1,7−オクタジエン−3−オン及びその製造方法 | |
Monk et al. | A general synthesis of 2-alkoxy-2-phenylpropanoic acids | |
US3652603A (en) | Method for production of 2 3-di(lower alkoxy)-5-methyl-1 4-benzoquinone | |
EP0019374B1 (de) | Verfahren zur Rückführung von Nebenprodukten bei der Herstellung von Niedrigalkylestern der 3.3-Dimethyl-4-pentensäure | |
JPH10306053A (ja) | エステルの製造方法 | |
US4235785A (en) | 4-Acetyl-2-alkoxy-7,7-dimethyl-3-oxabicyclo[4.1.0]heptane | |
US3914292A (en) | Process for preparing acyloxy-alkanals from cycloalkyl hydroperoxide and formic acid | |
JP3950492B2 (ja) | 光学活性含フッ素アルコールの製造方法 | |
JPH06107596A (ja) | テトラキス[3−(3,5−ジアルキル−4−ヒドロキシフェニル)プロピオニルオキシアルキル]メタンの製造方法 | |
JP2001252571A (ja) | キラル鉛触媒と不斉アルドール反応方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU NL SE |
|
17P | Request for examination filed |
Effective date: 19910925 |
|
17Q | First examination report despatched |
Effective date: 19930329 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU NL SE |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DK Effective date: 19940427 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 19940427 |
|
REF | Corresponds to: |
Ref document number: 104959 Country of ref document: AT Date of ref document: 19940515 Kind code of ref document: T |
|
REF | Corresponds to: |
Ref document number: 69101790 Country of ref document: DE Date of ref document: 19940601 |
|
ITF | It: translation for a ep patent filed |
Owner name: MODIANO & ASSOCIATI S.R.L. |
|
ET | Fr: translation filed | ||
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FG2A Ref document number: 2055926 Country of ref document: ES Kind code of ref document: T3 |
|
EAL | Se: european patent in force in sweden |
Ref document number: 91100046.1 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 19950131 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
26N | No opposition filed | ||
REG | Reference to a national code |
Ref country code: GB Ref legal event code: IF02 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20061227 Year of fee payment: 17 Ref country code: CH Payment date: 20061227 Year of fee payment: 17 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20061229 Year of fee payment: 17 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: NL Payment date: 20070103 Year of fee payment: 17 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: SE Payment date: 20070104 Year of fee payment: 17 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: AT Payment date: 20070111 Year of fee payment: 17 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: ES Payment date: 20070220 Year of fee payment: 17 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: BE Payment date: 20070314 Year of fee payment: 17 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: IT Payment date: 20070626 Year of fee payment: 17 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20070109 Year of fee payment: 17 |
|
BERE | Be: lapsed |
Owner name: *KURARAY CO. LTD Effective date: 20080131 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
EUG | Se: european patent has lapsed | ||
GBPC | Gb: european patent ceased through non-payment of renewal fee |
Effective date: 20080102 |
|
NLV4 | Nl: lapsed or anulled due to non-payment of the annual fee |
Effective date: 20080801 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20080801 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20080131 Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20080131 Ref country code: DE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20080801 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: AT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20080102 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: ST Effective date: 20081029 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20080102 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20080103 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20080131 |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FD2A Effective date: 20080103 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20080131 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: ES Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20080103 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20080102 |